The European Commission has approved the use of Remdesivir to treat severe cases of COVID-19. Meanwhile, the US has a record jump in cases for the second day in a row.
The announcement was made on Friday July 3, days after the US effectively stockpiled the world’s entire supply of the antiviral medication.
Its approval came after two major US studies showed that Remdesivir can reduce the duration of hospital stay for COVID-19 patients.
Remdesivir which is the only anti-coronavirus medication to be given the green light in the Europe, was originally intended as a treatment for Ebola.
Read Also: Update on Madagascar COVID-19 Cure
The green light comes on the recomendation of the European Medicines Agency which gave its conditional authorisation last week for the treatment of patients above 12 years of age who are suffering pneumonia and require extra oxygen.
It said its assessment was based mainly based on data from a study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)